Intravenous lidocaine: benefits require better evidence, and potential risks apply to all team members
- PMID: 33591568
- DOI: 10.1111/anae.15439
Intravenous lidocaine: benefits require better evidence, and potential risks apply to all team members
Comment on
-
Intravenous lidocaine: it's all about a risk-benefit analysis.Anaesthesia. 2021 May;76(5):717-718. doi: 10.1111/anae.15436. Epub 2021 Feb 16. Anaesthesia. 2021. PMID: 33591569 No abstract available.
References
-
- Hollmann MW, Hermanns H, Kranke P, Durieux ME. Intravenous lidocaine: it's all about a risk-benefit analysis. Anaesthesia 2021; 76: 717-8.
-
- Pandit JJ, McGuire N. Unlicensed intravenous lidocaine for postoperative pain: always a safer 'licence to stop' than to start. Anaesthesia 2021; 76: 156-60.
-
- Foo I, Macfarlane AJR, Srivastava D, et al. The use of intravenous lidocaine for postoperative pain and recovery: international consensus statement on efficacy and safety. Anaesthesia 2021; 76: 238-50.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
